Interferon Alpha-2a for the Treatment of Cystoid Macular Edema Secondary to Acute Retinal Necrosis.

Nihan Aksu Ceylan Zafer Cebeci Emre Altınkurt Nur Kır Mercül Merih Oray Carl P Herbort

Published in: Ocular immunology and inflammation (2021)

IFNα-2a is an effective therapeutic option for post-ARN CME, though side effects such as fatigue, elevated liver enzymes, neutropenia, and depression may limit tolerability. Lower initial doses may be a better tolerated.

Keyphrases

optical coherence tomography
diabetic retinopathy
dendritic cells
sleep quality
liver failure
immune response
open label
respiratory failure
aortic dissection
randomized controlled trial
hepatitis b virus
smoking cessation